- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Cancer (NSCLC)
Total 97086 results
-
Harrison Clinical ResearchMerck KGaA, Darmstadt, Germany; AstraZenecaCompletedHead and Neck Cancer | Colorectal Cancer | Non Small Cell Lung Cancer (NSCLC)Spain, Belgium
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
Fundacion Clinic per a la Recerca BiomédicaCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
Samsung Medical CenterNational Evidence-Based Healthcare Collaborating AgencyRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawnNon-small Cell Lung Cancer (NSCLC)United States
-
Ethicon Endo-Surgery (Europe) GmbHCompleted
-
Bristol-Myers SquibbCompletedLung Cancer (NSCLC)China, Germany, Singapore, Hungary, Korea, Republic of, Poland
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
University of Texas Southwestern Medical CenterCelgeneCompletedSTAGE IIIA/B NSCLC / INOPERABLE LUNG CANCERUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
Dr Joanne CHIURecruitingALK Gene Rearrangement Positive | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Activating Mutation | Nsclc | ROS1 Gene Rearrangement | ROS1 Positive NSCLC - Reactive Oxygen Species 1 Positive Non-Small Cell Lung CancerHong Kong
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
Nasser HannaGenentech, Inc.TerminatedNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Nasser HannaGenentech, Inc.RecruitingNSCLC | Lung CancerUnited States
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Shenzhen Geno-Immune Medical InstituteWithdrawn
-
Biomea Fusion Inc.RecruitingColorectal Cancer | Pancreatic Cancer | NSCLC | Non Small Cell Lung Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | CRC | KRAS Mutation-Related Tumors | Relapsed Cancer | Refractory Cancer | Stage IV Non-small Cell Lung Cancer | Stage IV Colorectal Cancer | Stage III Non-small Cell Lung Cancer | Stage III NSCLC and other conditionsUnited States, Korea, Republic of
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Beijing Chest HospitalUnknown
-
OSI PharmaceuticalsCompleted
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedNSCLCBulgaria, France, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom, Sweden, Poland, Ukraine, Chile, Hungary, Israel, Netherlands, Portugal, Romania, Germany, Austria, Belgium, Canada, Australia
-
Centre Henri BecquerelCompleted
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; Maastricht University Medical Center; Amsterdam... and other collaboratorsCompleted
-
Inge Marie SvaneCompletedNSCLC | Lung CancerDenmark
-
Marc de PerrotOzmosis Research Inc.Not yet recruitingNon-small Cell Lung Cancer (NSCLC) | Lung Cancer Patients
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Shanghai Chest HospitalRecruitingNSCLC | NSCLC Stage IV | NSCLC, RecurrentChina
-
Jun Zhang, MD, PhDRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Fudan UniversityNot yet recruitingNSCLC Stage IV | NSCLC, RecurrentChina
-
Peking University People's HospitalThe First Affiliated Hospital of Zhengzhou University; Jiangsu Cancer Institute... and other collaboratorsCompletedCarcinoma | Lung Neoplasms | NSCLC | Lung CancerChina
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.Active, not recruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States
-
Maastricht UniversityNot yet recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | NSCLC Stage IV
-
Shanghai University of Traditional Chinese MedicineCompletedNon-small Cell Lung Cancer(NSCLC)
-
University of Kansas Medical Centerparkview cancer instituteRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedNon Small Cell Lung Cancer (NSCLC) | Indication Mediastinal Staging | Complete EndosonographyNetherlands, Belgium
-
Taoyuan General HospitalUnknownNon-small Cell Lung Cancer (NSCLC) | Lung Metastasis